Supernus Pharma (SUPN.US) Latest Stock News - Major News Analysis

Event Tracking

Nov21

Supernus CEO to Attend Piper Sandler Healthcare Conference

21:06

Nov5

Supernus Pharma released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 192.1 M (forecast USD 180.22 M), actual EPS USD -0.8 (forecast USD -0.08)

00:00

Supernus Pharma released FY2025 9 Months Earnings on November 4 After-Market EST, with actual revenue of USD 507.38 M and EPS of USD -0.6117

00:00

Nov4

Supernus Pharmaceuticals Announces ONAPRO Supply Constraints and Raises Revenue Guidance

22:21

Supernus Pharmaceuticals Reports Q3 Operating Loss of $60.231 Million

21:01

Oct29

BofA Securities Upgrades Supernus Pharmaceuticals to Buy, Shares Rise

13:04

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 192.1 M, Net Income -45.12 M, EPS -0.8

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 165.45 M, Net Income 22.5 M, EPS 0.4

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 149.82 M, Net Income -11.83 M, EPS -0.2117

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change